---
title: "Molecular biology-of-NSCLC"
slug: "molecular-biology-of-nsclc"
date: "2023-11-02"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[NSCLC]]

# Molecular biology-of-NSCLC

- [[KRAS Mt]]
- [[EGFR Mt]]:
- [[ALK]]
- [[ROS1]]
- [[METex14]]
- [[BRAF V600E]]

## Other genomic features

    - Genome doubling,

- tobacco-induced mutagenesis (C>A, G>T transversions),
  - tumor suppressor loss-of-function Mt (TP53, STK11, KEAP1, CDKN2A, NF1),
- APOBEC-related subclonal Mt (Nat Gen 2018;50:1189; NEJM 2016;374:1864)

## SQCLCs

- Few RTK gene mutations;
- chr 3q Amp;
- common: TP53 (81%), CDKN2A loss (72%), RB1, PIK3CA, PTEN, NFE2L2, KEAP1, NOTCH1, SOX2 Amp, FGFR1 Amp, HLA-A loss (Nature 2012;489:519;
- J Clin Oncol 2012;30:abstr 7505) PD-L1 expression:
  - Scored by % membranous staining of viable tumor cells (TPS), immune cells (IC),
  - reflection of tumor inflammation â†‘ a/w â†‘ ICI response Tumor mutation burden (TMB): Nonsynonymous (coding) mutations measured as mutations/megabase (mt/mb) â†‘ TMB a/w â†‘ ICI response (Science 2015;348:124; Cancer Cell 2018;33:843) and a/w tobacco-induced mutagenesis
